Axcella Health

AXLA NASDAQ
7.41
+0.05
+0.68%
Opening 14:00 07/23 EDT
Open
7.41
Prev Close
7.36
High
7.41
Low
7.38
Volume
1.10K
Avg Vol (3M)
93.05K
52 Week High
15.99
52 Week Low
7.12
% Turnover
0.00%
Market Cap
170.34M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Axcella Health AXLA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Axcella Health Inc. is a biotechnology company. The Company focuses on research and development of multifactorial interventions to support health and address dysregulated metabolism across a spectrum of consumers. It designs and develops endogenous metabolic modulators. Its AXA Development Platform produces a pipeline of AXA candidates with programs in liver, muscle and blood. The Company’s wholly owned pipeline comprises five programs focused on the metabolic functions of the liver, muscle and blood. It offers AXA1665 for use in treating Hepatic Encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways.
MORE >

Recently

Name
Price
%Change